Neurofibromatosis type 1

被引:0
作者
Anders, Rebecca [1 ]
Hirsch, Franz Wolfgang [1 ]
Roth, Christian [1 ,2 ]
机构
[1] Univ Klinikum Leipzig, Inst Kinderradiol, Leipzig, Germany
[2] Univ Klinikum Leipzig, Inst Kinderradiol, Liebigstr 20a, D-04103 Leipzig, Germany
来源
PAEDIATRIE UND PAEDOLOGIE | 2024年 / 59卷 / 02期
关键词
Optic glioma; Neurofibroma; Genetic predisposition; Magnetic resonance imaging; Recommendations; OPTIC PATHWAY GLIOMAS; EVOLUTION; CHILDREN; MRI; NF1;
D O I
10.1007/s00608-024-01209-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Neurofibromatosis type 1 (NF1) is a tumor predisposition syndrome and is one of the most common genetic diseases. It is therefore a condition encountered by radiologists in clinical routine. Since the variability of the clinical expression is very high and several organ systems are affected, we present a standardized diagnostic approach in this article. Methods: Evaluation of the literature on neurofibromatosis type 1 in the context of radiological examination methods. Results: In addition to the frequently known changes in the central and peripheral nervous system such as optic gliomas and plexiform neurofibromas, lesions from the orthopedic spectrum and vascular changes must also be included in the radiological diagnosis. Conclusions: Due to the diversity of the clinical picture of NF1, it is reasonable to define an examination strategy which takes into account the needs of radiological routine and also reliably detects the most frequent and prognostically significant pathologies accompanying this disease. In this article, the current recommendations for diagnosis of neurofibromatosis-associated tumors and skeletal changes are summarized, and examination protocols and time intervals are suggested.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 50 条
  • [31] Growth and Pubertal Development of Neurofibromatosis Type 1 Patients
    Oliveira, Catia Priscila
    Santos-Silva, Rita
    Fontoura, Manuel
    [J]. REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2019, 14 (02) : 180 - 186
  • [32] Ocular motility abnormalities in orbitofacial neurofibromatosis type 1
    Oystreck, Darren T.
    Alorainy, Ibrahim A.
    Morales, Jose
    Chaudhry, Imtiaz A.
    Elkhamary, Sahar M.
    Bosley, Thomas M.
    [J]. JOURNAL OF AAPOS, 2014, 18 (04): : 338 - 343
  • [33] Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome
    Garzon, Jenny P.
    Patete, Andrea
    Aschbacher-Smith, Lindsey
    Qu'd, Dima
    Kelly-Mancuso, Geraldine
    Raski, Carolyn R.
    Weisman, Allison Goetsch
    Hankins, Madison
    Sawin, Michael
    Kim, Katherine
    Drackley, Andy
    Zeid, Janice
    Weaver, K. Nicole
    Hopkin, Robert J.
    Saal, Howard M.
    Charrow, Joel
    Schorry, Elizabeth
    Listernick, Robert
    Simpson, Brittany N.
    Prada, Carlos E.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2024, 196 (04)
  • [34] Neurofibromatosis Type 1: Review and Update on Emerging Therapies
    Karaconji, Tanya
    Whist, Eline
    Jamieson, Robyn V.
    Flaherty, Maree P.
    Grigg, John R. B.
    [J]. ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2019, 8 (01): : 62 - 72
  • [35] Resection of Plexiform Neurofibromas in Children With Neurofibromatosis Type 1
    Canavese, Federico
    Krajbich, Joseph I.
    [J]. JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2011, 31 (03) : 303 - 311
  • [36] Oncologic manifestations in children with neurofibromatosis type 1 in Turkey
    Incecik, Faruk
    Altunbasak, Sakir
    Herguner, M. Ozlem
    Bayram, Ibrahim
    Kupeli, Serhan
    Demirbilek, Huseyin
    [J]. TURKISH JOURNAL OF PEDIATRICS, 2013, 55 (03) : 266 - 270
  • [37] An Update on Neurofibromatosis Type 1-Associated Gliomas
    Lobbous, Mina
    Bernstock, Joshua D.
    Coffee, Elizabeth
    Friedman, Gregory K.
    Metrock, Laura K.
    Chagoya, Gustavo
    Elsayed, Galal
    Nakano, Ichiro
    Hackney, James R.
    Korf, Bruce R.
    Nabors, Louis B.
    [J]. CANCERS, 2020, 12 (01)
  • [38] Updates in the Management of Central and Peripheral Nervous System Tumors among Patients with Neurofibromatosis Type 1 and Neurofibromatosis Type 2
    Kotch, Chelsea
    Brosius, Stephanie Nicole
    De Raedt, Thomas
    Fisher, Michael Jay
    [J]. PEDIATRIC NEUROSURGERY, 2023, 58 (05) : 267 - 280
  • [39] Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?
    Guler, Serhat
    Yesil, Gozde
    Onal, Hasan
    [J]. BALKAN MEDICAL JOURNAL, 2017, 34 (06) : 522 - 526
  • [40] The Diagnosis and Management of Neurofibromatosis Type 1
    Ly, K. Ina
    Blakeley, Jaishri O.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (06) : 1035 - +